Thus, we conclude that miR-320a inhibits CML cell migration, invasion and proliferation, as well as promoting apoptosis, by decreasing the expression of BCR/ABL, which increases PI3K, AKT and NF-κB signaling. Here, NFKB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.